肝癌介入治疗后心脏并发症的预防及治疗

Prevention and treatment of the cardiac complication in the patients with primary hepatocellular carcinoma after interventional therapy

目的 :探讨肝癌介入治疗后心脏并发症发生的原因及预防、处理措施。方法 :原发性肝癌病人 4例 ,年龄 36～ 6 5岁。所有病人接受经导管肝动脉化疗栓塞 (TAE)治疗 ,术后进行心电监护、心电图检查和心肌酶谱 (HEA)检查。结果 :4例病人均有心前区不适感 ,T波轻度改变 ,心型肌酸激酶 (CK MB)升高 ,提示有心肌受损现象。经治疗后 ,3例治愈出院 ,1例因多器官功能衰竭死亡。结论 :肝癌介入治疗后心脏并发症是一种少见的并发症 ,如能早期发现 ,并及时处理 。

Objective:To investigate the causes of cardiac complication and method of prevention and treatment in the patients with primary hepatocellular carcinoma (HCC) after interventional therapy.Methods:4 cases of HCC,aged from 36 to 65 yrs,were followed up continuous electrocardiogram monitoring,and examinations of electrocardiogram and HEA after TAE.Results:Precordial fullness,the anomaly of T wave on electrocardiogram and elevation of CK MB in 4 cases indicated the damage of myocardium.After therapy,3 cases were healed to discharge from hospital and one died of several organ failure.Conclusion:The cardiac complications in the patients with HCC after interventional therapy are uncommon and the patients will get over if the complication is detected early and managed simultaneously .